Recombinant Lactobacillus johnsonii Elongation factor Tu (tuf)

Shipped with Ice Packs
In Stock

Description

Identification and Function of EF-Tu in Lactobacillus johnsonii

Research has identified EF-Tu as a surface molecule in Lactobacillus johnsonii NCC533 (La1) that mediates the bacterium's attachment to intestinal epithelial cells and mucins . Studies have confirmed the presence of EF-Tu on the surface of La1 through immunoblotting, electron microscopy, and enzyme-linked immunosorbent assays .

Key findings regarding the function of EF-Tu in Lactobacillus johnsonii:

  • Adhesion: EF-Tu acts as an adhesion factor, facilitating the binding of L. johnsonii to intestinal cells and mucins .

  • pH Dependence: The binding of EF-Tu to intestinal cells and mucins is pH-dependent .

  • Mucin Binding: EF-Tu plays a significant role in the mucin-binding capacity of L. johnsonii . Competition experiments have demonstrated that EF-Tu can prevent the binding of mucins to L. johnsonii bacteria .

  • Immunomodulation: EF-Tu can induce a pro-inflammatory response in intestinal cells in the presence of soluble CD14, suggesting its involvement in gut homeostasis .

Recombinant Production and Characteristics

Recombinant EF-Tu can be produced in other organisms like E. coli and then purified for use in experiments examining its properties . Recombinant EF-Tu from Lactobacillus reuteri is also available for purchase, with the following characteristics :

PropertyValue
Species reactivityLactobacillus reuteri
Molecular weight50.9 kD
Purity>90% (SDS-PAGE)
HostE. coli
ApplicationActivity not tested
KEGG IDK02358
UniProt IDA5VJ92
Gene IDGeneID 77190802
Storage temperature-20°C

Applications of Recombinant Lactobacillus johnsonii

Genetic engineering can modify Lactobacillus johnsonii to express specific proteins, enhancing its therapeutic potential . For example, a recombinant Lactobacillus johnsonii strain has been engineered to express bovine Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) to reduce postpartum uterine inflammation in bovines .

The recombinant L. johnsonii strain expressing GM-CSF showed the following effects :

  • Reduced levels of inflammatory markers (IL-6, IL-1β, TNF-α).

  • Decreased myeloperoxidase (MPO) activity and nitric oxide (NO) concentration.

  • Improved uterine morphology and reduced pathological damage.

  • Beneficial effects on bovine endometritis by reducing levels of inflammatory cytokines.

EF-Tu as a Moonlighting Protein

EF-Tu exhibits diverse "moonlighting" functions on the extracellular surface of both eukaryotic and prokaryotic cells, beyond its primary role in protein synthesis . These functions include interacting with membrane receptors and the extracellular matrix . For instance, EF-Tu of Mycoplasma pneumoniae binds fibronectin, while EF-Tu of Lactobacillus johnsonii mediates attachment to mucins . Additionally, recombinant EF-Tu of Pseudomonas aeruginosa binds human complement regulators, contributing to immune evasion .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tuf; LJ_1009Elongation factor Tu; EF-Tu
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-396
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Lactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533)
Target Names
tuf
Target Protein Sequence
MAEKEHYERT KPHVNIGTIG HVDHGKTTLT AAITTVLAED GLAQAEDYSQ IDAAPEEKER GITINTAHVE YETKNRHYAH MDAPGHADYI KNMITGAAQM DGAILVVAAT DGPMPQTREH ILLARQVGVQ YIVVFLNKVD LVDDPELIDL VEMEVRDLLS EYDYPGDDVP VIRGSALKAL EGDPEQQDVI RKLMETVDEY IPTPERDTDK PFLMPVEDVF TITGRGTVAS GRIDRGTVKV GDEVEIVGLT DKIEKSTVTG LEMFHKTLDL GEAGDNVGVL LRGIDRDQVE RGQVLAAPGS IQTHKNFKGQ VYILNKDEGG RHTPFFSDYR PQFYFHTTDV TGKIELPEGT EMVMPGDNVE FTVELIKPVA IEKGTKFTIR EGGKTVGAGQ VTEILD
Uniprot No.

Target Background

Function
This protein facilitates the GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during protein biosynthesis.
Database Links

KEGG: ljo:LJ_1009

STRING: 257314.LJ1009

Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Elongation Factor Tu (EF-Tu) and how is it expressed in Lactobacillus johnsonii?

Elongation Factor Tu (EF-Tu) is traditionally recognized as a cytoplasmic protein involved in protein synthesis, but in Lactobacillus johnsonii NCC533 (La1), it also functions as a surface-expressed molecule. Tandem mass spectrometry analysis has confirmed that EF-Tu is expressed on the La1 surface as an intact molecule, not as fragments. The surface localization has been verified through multiple techniques including immunoblotting experiments, electron microscopy, and enzyme-linked immunosorbent assays of live bacteria . The expression of EF-Tu at the bacterial surface represents a non-canonical function beyond its classical role in translation, suggesting evolutionary adaptations that may contribute to the ecological fitness of L. johnsonii in its host environment.

What adhesive properties does L. johnsonii EF-Tu exhibit?

EF-Tu from L. johnsonii NCC533 (La1) demonstrates specific adhesin-like properties in the intestinal environment. Experimental evidence shows that recombinant La1 EF-Tu protein binds to intestinal epithelial cells (such as Caco-2 cells) and mucins. This binding capability is notably pH-dependent, suggesting a mechanism attuned to specific intestinal microenvironments. Competition experiments have further established that EF-Tu plays a significant role in La1's mucin binding capacity . Methodologically, these adhesive properties can be assessed through in vitro binding assays using recombinant EF-Tu protein and intestinal cell lines, with quantification via enzyme-linked immunosorbent assays or immunofluorescence microscopy.

How do researchers differentiate Lactobacillus johnsonii from closely related species when studying EF-Tu?

Differentiating L. johnsonii from closely related species, particularly L. gasseri and L. taiwanensis, requires a combination of molecular and comparative genomics methods. Phylogenetic analysis using multiple gene sequences (16S rRNA, recA, pheS, pyrG, and tuf) provides initial species identification. DNA-DNA hybridization experiments confirm distinct but close relationships between these species. For more precise discrimination, Comparative Genomic Hybridization (CGH) using DNA microarrays designed for L. johnsonii can be employed . When specifically studying EF-Tu, researchers should sequence the tuf gene, which encodes for EF-Tu, and compare it with reference sequences. Additionally, terminal restriction fragment length polymorphism (tRFLP) can be used as part of the isolation procedure to identify L. johnsonii within a selected spectrum of lactic acid bacteria .

What techniques are most effective for recombinant production and purification of L. johnsonii EF-Tu?

For optimal recombinant production of L. johnsonii EF-Tu, researchers should employ a methodological approach that preserves the protein's functional characteristics. The recommended procedure involves:

  • Gene amplification of the tuf gene from L. johnsonii genomic DNA using high-fidelity polymerase and specific primers designed to incorporate appropriate restriction sites.

  • Cloning into an expression vector with an inducible promoter and affinity tag (such as His-tag or GST-tag) for purification.

  • Expression in a suitable bacterial host system, with E. coli BL21(DE3) often preferred due to its reduced protease activity.

  • Optimization of induction conditions (temperature, IPTG concentration, and duration) to maximize soluble protein yield.

  • Purification via affinity chromatography, followed by size-exclusion chromatography to remove aggregates and obtain homogeneous protein.

For functional studies, it is critical to verify that the recombinant EF-Tu retains its native conformation and binding properties through circular dichroism spectroscopy and binding assays with intestinal cells and mucins . Tag removal may be necessary for some applications, particularly those involving immunological studies, to prevent interference with protein function or introduction of artificial immunogenic epitopes.

How can researchers effectively analyze the immunomodulatory effects of recombinant L. johnsonii EF-Tu?

Analysis of the immunomodulatory effects of recombinant L. johnsonii EF-Tu requires a comprehensive experimental approach. Based on current research, EF-Tu can induce a proinflammatory response in HT29 cells in the presence of soluble CD14 . A systematic methodology should include:

  • Cell culture models: Employing intestinal epithelial cell lines (HT29, Caco-2) and immune cells (macrophages, dendritic cells) in co-culture systems.

  • Cytokine profiling: Measuring the induction of multiple cytokines (IL-6, IL-8, TNF-α, IL-10) using ELISA or cytometric bead arrays following exposure to recombinant EF-Tu.

  • Signaling pathway analysis: Investigating activation of NF-κB and MAPK pathways through Western blotting, reporter assays, or phosphoprotein arrays.

  • Dose-response relationships: Establishing optimal concentrations of recombinant EF-Tu for immunomodulatory effects.

  • Time-course experiments: Determining the kinetics of the immune response.

  • Receptor identification: Using blocking antibodies or knockout cell lines to identify the receptors involved (beyond CD14).

Researchers should include appropriate controls, such as heat-inactivated EF-Tu, other surface proteins from L. johnsonii, and EF-Tu from non-probiotic bacteria, to establish specificity of the observed effects .

What are the mechanistic differences in EF-Tu function between L. johnsonii and other Lactobacillus species?

  • Sequence homology: Comparing the amino acid sequence of EF-Tu across Lactobacillus species (L. acidophilus, L. paracasei, L. gasseri, L. reuteri) to identify conserved and variable regions that might explain functional differences .

  • Surface localization: Determining whether EF-Tu is consistently expressed on the surface of other Lactobacillus species using the same methodologies applied to L. johnsonii (immunoblotting, electron microscopy, and enzyme-linked immunosorbent assays) .

  • Binding properties: Comparing the adhesive capabilities of EF-Tu from different species to intestinal cells and mucins, including pH-dependency of binding.

  • Immunomodulatory potential: Assessing species-specific differences in the ability to induce cytokine responses.

  • Host specificity: Evaluating whether EF-Tu contributes to the observed host specificity of L. johnsonii strains, which form distinct clusters based on their host origin (human, chicken, or mouse) .

This comparative approach would require cloning, expression, and purification of EF-Tu from multiple Lactobacillus species, followed by functional assays under standardized conditions.

What are the critical parameters for studying pH-dependent binding of L. johnsonii EF-Tu to intestinal cells and mucins?

When investigating the pH-dependent binding of L. johnsonii EF-Tu to intestinal cells and mucins, researchers must carefully control several critical parameters:

  • pH range selection: Test a physiologically relevant pH gradient (pH 4.0-8.0) that encompasses the varying conditions throughout the gastrointestinal tract.

  • Buffer composition: Use buffers that maintain stable pH without interfering with protein-cell interactions (e.g., phosphate-buffered saline, HEPES, or MES buffers at appropriate pH values).

  • Mucin source and preparation: Employ both commercially available purified mucins and freshly isolated mucins from relevant species. Ensure proper solubilization and coating conditions for in vitro binding assays.

  • Cell model selection: Use intestinal epithelial cell lines (Caco-2, HT29) at appropriate differentiation stages, as differentiation affects mucin expression and composition.

  • Binding quantification: Implement multiple complementary techniques such as ELISA, surface plasmon resonance, and fluorescence-based assays with labeled recombinant EF-Tu.

  • Competition assays: Include unlabeled EF-Tu at various concentrations to demonstrate binding specificity .

  • Kinetic measurements: Determine association and dissociation rates at different pH values to characterize the binding dynamics.

  • Structural integrity verification: Confirm that pH changes do not affect EF-Tu structure using circular dichroism or fluorescence spectroscopy.

The experimental design should include appropriate controls such as other L. johnsonii surface proteins and EF-Tu from non-adhesive bacterial species to establish specificity of the observed pH-dependent interactions.

How should researchers design experiments to study the host specificity of L. johnsonii EF-Tu?

Designing experiments to study the host specificity of L. johnsonii EF-Tu requires a comprehensive approach that integrates genetic, structural, and functional analyses:

  • Strain collection and genomic analysis:

    • Isolate L. johnsonii strains from diverse hosts (humans, chickens, mice, and other animals)

    • Sequence the tuf gene from these isolates

    • Perform phylogenetic analysis to identify host-specific sequence variations

  • Recombinant protein production:

    • Express and purify EF-Tu from strains isolated from different hosts

    • Verify structural integrity through circular dichroism and thermal stability assays

  • Binding specificity assays:

    • Test binding of different EF-Tu variants to intestinal epithelial cells and mucins from corresponding host species

    • Conduct cross-binding experiments (e.g., human L. johnsonii EF-Tu binding to mouse intestinal cells)

    • Quantify binding affinities using surface plasmon resonance or similar techniques

  • Domain mapping:

    • Create chimeric proteins by swapping domains between EF-Tu variants from different hosts

    • Identify regions responsible for host-specific binding

  • In vivo colonization studies:

    • Generate L. johnsonii mutants with EF-Tu variants from different hosts

    • Assess colonization efficiency in different animal models

    • Monitor persistence through fecal sampling and quantitative PCR

This experimental framework would provide insights into whether EF-Tu contributes to the observed host specificity of L. johnsonii strains, which form distinct clusters based on their host origin .

What controls are essential when assessing the immunomodulatory effects of recombinant L. johnsonii EF-Tu?

When assessing the immunomodulatory effects of recombinant L. johnsonii EF-Tu, the following essential controls must be included to ensure valid and interpretable results:

  • Protein-specific controls:

    • Heat-denatured EF-Tu to distinguish structure-dependent effects

    • Purification tag-only protein to control for tag-induced effects

    • Size-matched unrelated protein purified using the same protocol

    • EF-Tu from non-probiotic bacteria (e.g., E. coli) to determine species-specific effects

  • Endotoxin controls:

    • Endotoxin-free preparation verification using LAL assay

    • Polymyxin B treatment to neutralize potential LPS contamination

    • TLR4 antagonist controls to distinguish EF-Tu effects from LPS effects

  • Cell system controls:

    • Unstimulated cells as negative controls

    • Positive controls for inflammatory response (e.g., LPS, TNF-α)

    • Cell viability assessment to rule out cytotoxicity effects

    • CD14-blocking antibodies to confirm the dependency on soluble CD14

  • Pathway controls:

    • Specific pathway inhibitors (e.g., NF-κB inhibitors)

    • Receptor blocking antibodies

    • Knockdown/knockout cell lines for specific receptors or adaptor molecules

  • Validation controls:

    • Multiple cell lines to ensure cell-type independence of effects

    • Primary cells to confirm relevance beyond cell lines

    • Dose-response relationships to establish physiological relevance

Implementing these controls systematically will help distinguish specific immunomodulatory effects of L. johnsonii EF-Tu from non-specific effects or experimental artifacts.

How can researchers differentiate between direct and indirect immunomodulatory effects of L. johnsonii EF-Tu?

Differentiating between direct and indirect immunomodulatory effects of L. johnsonii EF-Tu presents significant analytical challenges. To address this, researchers should implement a systematic approach:

  • Receptor identification studies:

    • Perform receptor blocking experiments using antibodies against potential receptors

    • Use receptor knockout cell lines

    • Conduct direct binding assays between purified EF-Tu and potential receptors

    • Employ proximity ligation assays to visualize receptor interactions in situ

  • Signaling pathway dissection:

    • Use specific inhibitors targeting different components of immune signaling pathways

    • Track activation kinetics through phosphorylation assays

    • Employ reporter cell lines for specific transcription factors (NF-κB, AP-1, IRF)

    • Conduct RNA-seq at early time points to identify primary response genes

  • Co-culture systems:

    • Design transwell experiments separating different cell types

    • Use conditioned media transfer between cell types

    • Employ cytokine neutralizing antibodies to block secondary effects

    • Compare results from monoculture vs. co-culture conditions

  • Temporal analysis:

    • Conduct detailed time-course experiments to separate early (likely direct) from late (possibly indirect) effects

    • Use protein synthesis inhibitors to distinguish effects requiring new protein synthesis

    • Monitor the sequential activation of different cell types in mixed cultures

The research has shown that EF-Tu can induce a proinflammatory response in HT29 cells in the presence of soluble CD14 , suggesting a direct effect through CD14-dependent pathways, but further studies are needed to fully characterize the mechanisms involved.

What statistical approaches are most appropriate for analyzing host-specificity data of L. johnsonii strains?

When analyzing host-specificity data of L. johnsonii strains, particularly in relation to EF-Tu function, several statistical approaches are recommended for robust interpretation:

  • Hierarchical clustering and principal component analysis (PCA):

    • Apply these methods to genetic data (SSR loci variations and MLST data) to visualize clustering of strains by host origin

    • Validate cluster significance using bootstrap or jackknife resampling methods

  • Phylogenetic analyses:

    • Construct maximum likelihood or Bayesian phylogenetic trees

    • Perform statistical tests such as the Shimodaira-Hasegawa test to compare alternative tree topologies

    • Calculate genetic distances within and between host-specific clusters

  • Analysis of molecular variance (AMOVA):

    • Partition genetic variance within and among host-specific populations

    • Test significance of population structure using permutation tests

  • Discriminant analysis of principal components (DAPC):

    • Identify genetic variables that best explain host-specific clustering

    • Calculate membership probabilities for each strain to host-specific groups

  • Functional data analysis:

    • For binding assays comparing EF-Tu from different host-specific strains, use:

      • Two-way ANOVA with post-hoc tests for multiple comparisons

      • Linear mixed-effect models to account for batch effects and repeated measures

      • Non-parametric alternatives (Kruskal-Wallis, permutation tests) when assumptions are violated

  • Correlation analyses:

    • Use Mantel tests to correlate genetic distance matrices with functional distance matrices

    • Apply partial least squares regression to identify genetic variations associated with functional differences

These statistical approaches should be selected based on data structure and specific research questions, with appropriate correction for multiple testing when applicable.

How should conflicting data on the immunomodulatory effects of L. johnsonii EF-Tu be reconciled?

When faced with conflicting data on the immunomodulatory effects of L. johnsonii EF-Tu, researchers should adopt a systematic reconciliation approach:

  • Methodological comparison and standardization:

    • Critically evaluate differences in experimental protocols (protein purification methods, endotoxin removal, cell models, incubation conditions)

    • Replicate key experiments using standardized protocols

    • Collaborate with laboratories reporting discrepant results to perform side-by-side comparisons

  • Strain-specific variation analysis:

    • Determine if conflicting results stem from genetic variations in EF-Tu between different L. johnsonii strains

    • Sequence the tuf gene from strains used in different studies

    • Express and test EF-Tu from multiple strains under identical conditions

  • Context-dependent effects assessment:

    • Investigate whether discrepancies arise from different experimental contexts

    • Test EF-Tu effects under varying conditions:

      • Different pH levels

      • Presence/absence of soluble CD14

      • Various cell activation states

      • Different cell types and co-culture systems

  • Dose-response and kinetic reconciliation:

    • Conduct comprehensive dose-response studies across a wide concentration range

    • Perform detailed time-course experiments to capture transient effects

    • Create mathematical models that might explain apparently conflicting observations as different aspects of a complex response

  • Meta-analysis approach:

    • Systematically review all available data

    • Apply appropriate statistical methods to integrate findings across studies

    • Identify moderator variables that might explain heterogeneity in results

  • Biological variance acknowledgment:

    • Consider that apparent contradictions may reflect genuine biological complexity

    • Design experiments to test whether EF-Tu effects are:

      • Cell-type specific

      • Species-specific

      • Dependent on microenvironmental factors

This structured approach allows researchers to determine whether conflicting data represent truly contradictory findings or simply different facets of EF-Tu's complex immunomodulatory activities.

What are the most promising applications of recombinant L. johnsonii EF-Tu in microbiome research?

The emerging understanding of L. johnsonii EF-Tu offers several promising research directions for microbiome studies:

  • Microbial adaption and host-microbe co-evolution:

    • Using EF-Tu as a marker to study host-specific adaptation of L. johnsonii strains

    • Investigating evolutionary patterns of surface-expressed EF-Tu across different Lactobacillus species

    • Examining how EF-Tu sequence variations correlate with host phylogeny

  • Microbiome engineering and synthetic biology:

    • Developing engineered L. johnsonii strains with modified EF-Tu to enhance colonization capabilities

    • Creating chimeric probiotics with optimized adhesion and immunomodulatory properties

    • Designing "smart" probiotics that respond to specific intestinal microenvironments through pH-dependent EF-Tu binding

  • Microbiome-immune system interaction mapping:

    • Using EF-Tu as a model to understand how commensal bacteria communicate with the host immune system

    • Developing systems biology models of how bacterial surface proteins like EF-Tu contribute to gut homeostasis

    • Investigating the role of EF-Tu in training the mucosal immune system and establishing tolerance to commensals

  • Diagnostic applications:

    • Developing antibody-based assays targeting strain-specific EF-Tu epitopes for microbiome composition analysis

    • Creating biosensors that detect L. johnsonii colonization through EF-Tu recognition

    • Using EF-Tu sequence variants as biomarkers for host-adapted strains in microbiome samples

  • Therapeutic potential:

    • Exploring recombinant EF-Tu as a postbiotic agent that could provide benefits without requiring live bacteria

    • Investigating whether EF-Tu could be used to modulate specific immune responses in inflammatory conditions

    • Studying EF-Tu-derived peptides as potential immunomodulatory agents

These research directions leverage our understanding of EF-Tu's dual role in L. johnsonii as both a cytoplasmic protein involved in translation and a surface-expressed molecule involved in host interaction .

What methodological advances are needed to better characterize the structural basis of EF-Tu host interactions?

Advancing our understanding of the structural basis of EF-Tu host interactions requires several methodological innovations:

  • High-resolution structural analysis techniques:

    • Cryo-electron microscopy of EF-Tu bound to intestinal cell receptors or mucins

    • X-ray crystallography of EF-Tu in complex with host factors

    • NMR studies of the dynamic interactions between EF-Tu and host molecules

    • Hydrogen-deuterium exchange mass spectrometry to map binding interfaces

  • Advanced mutagenesis approaches:

    • Systematic alanine scanning of the EF-Tu surface

    • Deep mutational scanning coupled with binding selection assays

    • CRISPR-based precision editing of the tuf gene in native L. johnsonii

    • Creation of domain-swapped variants between EF-Tu from different host-specific strains

  • Single-molecule interaction techniques:

    • Atomic force microscopy to measure binding forces

    • Single-molecule FRET to analyze conformational changes upon binding

    • Optical tweezers to characterize the mechanical properties of EF-Tu-mucin interactions

    • Total internal reflection fluorescence microscopy to visualize individual binding events

  • In situ imaging methods:

    • Super-resolution microscopy of EF-Tu distribution on L. johnsonii surface

    • Expansion microscopy to visualize EF-Tu interactions with intestinal tissue

    • Correlative light and electron microscopy to connect functional and structural data

    • Click chemistry-based approaches for in vivo labeling of EF-Tu interactions

  • Computational methods:

    • Molecular dynamics simulations of EF-Tu interactions with mucins and cell receptors

    • Machine learning approaches to predict binding interfaces from sequence data

    • Integrative modeling combining data from multiple experimental techniques

    • Systems biology models of how EF-Tu binding affects bacterial adhesion and host responses

These methodological advances would help resolve the structural determinants of the pH-dependent binding of EF-Tu to intestinal cells and mucins , as well as the potential basis for host specificity.

How might the understanding of L. johnsonii EF-Tu inform design of next-generation probiotics?

The emerging understanding of L. johnsonii EF-Tu offers valuable insights for designing next-generation probiotics with enhanced functionality:

  • Strain selection strategies:

    • Screening for L. johnsonii strains with optimized EF-Tu expression and binding properties

    • Selecting strains with host-adapted EF-Tu variants based on phylogenetic analysis

    • Identifying strains with balanced immunomodulatory profiles through systematic EF-Tu characterization

  • Rational strain engineering approaches:

    • Modifying the tuf gene to enhance adhesion to specific intestinal regions

    • Engineering pH-responsive EF-Tu variants for targeted activity in different gut compartments

    • Creating strains with modified EF-Tu that selectively modulate specific immune pathways

    • Developing strains with controlled surface expression levels of EF-Tu

  • Combination probiotic design:

    • Formulating synbiotic combinations where EF-Tu-mediated adhesion is complemented by other beneficial properties

    • Creating defined multi-strain consortia with complementary EF-Tu immunomodulatory profiles

    • Designing strain combinations that collectively provide optimal EF-Tu-driven effects across varying gut conditions

  • Biomarker-guided personalization:

    • Using host genetic or microbiome biomarkers to match individuals with L. johnsonii strains having appropriate EF-Tu variants

    • Developing diagnostic tools to predict responsiveness to EF-Tu-mediated effects

    • Creating personalized probiotic regimens based on intestinal mucin profiles that interact optimally with specific EF-Tu variants

  • Delivery system optimization:

    • Designing encapsulation methods that protect L. johnsonii while allowing EF-Tu-mediated interactions upon release

    • Developing pH-triggered release systems that complement the natural pH-dependency of EF-Tu binding

    • Creating bioadhesive formulations that enhance EF-Tu-mucin interactions in specific intestinal regions

This knowledge-based approach to probiotic design moves beyond traditional empirical methods, leveraging the molecular understanding of how L. johnsonii interacts with the host through surface molecules like EF-Tu to create probiotics with enhanced efficacy and specificity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.